Improved sensitivity to activated protein C following postmenopausal hormone replacement therapy [2]

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 3, 1998, Pages 293-294

  De Mitrio, V ^a,b   Marino, R ^a   Giannoccaro, F ^a   Galantino, P ^a   Cicinelli, E ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b School of Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ADULT; CLINICAL ARTICLE; DRUG FORMULATION; DRUG POTENTIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BINDING; STATISTICAL ANALYSIS; THROMBOPLASTIN TIME; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031802806     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199804000-00014     Document Type: Letter

References (9)

1. Mcade TM. Hormone replacement therapy and haemostatic function. Thromb Haemost 1997; 78: 765-769.
2. Falkeborn M, Persson I, Adami HO, Bergstrom R, Eaker E, Lithell H, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821-828.
3. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-461.
4. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993; 153: 1201-1209.
5. Bertina RM. Laboratory diagnosis of resistance to activated protein C (APC-resistance). Thromb Haemost 1997; 78: 478-482.
6. Henkens CMA, Bom VJJ, van der Meer J. Sensitivity to activated protein C; influence of oral contraceptives and sex. Thromb Haemost 1995; 73: 402-404.
7. Henkens CMA, Born VJJ, Seinen AJ, van der Meer J. Lowered APC-sensitivity ratio related to increased factor VHI-clotting activity. Thromb Haemost 1995; 74: 1198-1199.
8. Honovic L, Zadro R, Suchanek E, Cubrillo-Turck M, Stavljenic-Rukavina A. The effect of hormonal replacement therapy on APC-sensitivity [abstract]. Thromb Haemost 1997; 78 (suppl): 319.
9. Laffan MA, Manning R. The influence of factor VIII measurement of activated protein C resistance. Blood Coag Fibrinol 1996; 7: 761-765.